Search

Your search keyword '"Kubo, S"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Kubo, S" Remove constraint Author: "Kubo, S" Topic bile duct neoplasms Remove constraint Topic: bile duct neoplasms
61 results on '"Kubo, S"'

Search Results

1. Impact of Tumor Subclassifications for Identifying an Appropriate Surgical Strategy in Patients with Intrahepatic Cholangiocarcinoma.

2. Development of intraductal papillary neoplasm of the bile duct in patients with occupational cholangiocarcinoma.

3. Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21.

4. Nivolumab for treating patients with occupational cholangiocarcinoma.

5. Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case report.

6. Fibroblast growth factor receptor 2 (FGFR2) fusions in Japanese patients with intrahepatic cholangiocarcinoma.

7. Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis.

8. A case of primary hepatic mixed neuroendocrine-non-neuroendocrine tumor (MiNEN) associated with gallbladder carcinosarcoma.

9. Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy.

10. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.

11. Surgical Outcomes of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Korea-Japan Multicenter Study.

12. Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan.

13. Indications for laparoscopic liver resection of mass-forming intrahepatic cholangiocarcinoma.

14. Programmed death-1 inhibitor for occupational intrahepatic cholangiocarcinoma caused by chlorinated organic solvents.

15. The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational Cholangiocarcinoma

16. MR imaging and MR cholangiopancreatography of cholangiocarcinoma developing in printing company workers.

17. Low Incidence of Lymph Node Metastasis After Resection of Hepatitis Virus-Related Intrahepatic Cholangiocarcinoma.

18. The PD-1/PD-L1 axis may be aberrantly activated in occupational cholangiocarcinoma.

19. Outcomes after resection of occupational cholangiocarcinoma.

20. Relationship between cumulative exposure to 1,2-dichloropropane and incidence risk of cholangiocarcinoma among offset printing workers.

21. Comparison of clinicopathological characteristics between patients with occupational and non-occupational intrahepatic cholangiocarcinoma.

22. The association between non-alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: A hospital based case-control study.

23. Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents.

24. Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma.

25. Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.

26. [Occupational cholangiocarcinoma in a printer that responded to neoadjuvant chemoradiotherapy].

27. Comparison of Clinical Characteristics between Occupational and Sporadic Young-Onset Cholangiocarcinoma.

28. Re: Occupational cholangiocarcinoma.

29. Chemical exposure levels in printing and coating workers with cholangiocarcinoma (third report).

30. Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma.

31. Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan.

32. Proposal of a new staging system for mass-forming intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

33. Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan.

34. Surgical treatment for intrahepatic cholangiocarcinoma.

36. Changes in laboratory test results and diagnostic imaging presentation before the detection of occupational cholangiocarcinoma.

38. Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

39. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma.

40. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases.

41. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.

42. Adenomyoma of the common hepatic duct mimicking bile duct cancer: report of a case.

44. A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis.

45. Two cases of intrahepatic cholangiocarcinoma detected after interferon therapy for chronic hepatitis C.

47. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.

48. Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma.

49. A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker.

50. Portal thrombosis due to intrahepatic cholangiocarcinoma following successful treatment for hepatocellular carcinoma.

Catalog

Books, media, physical & digital resources